Treatment Areas

FDA Approves CBD Treatment for Seizures in Rare Genetic Disease

August 04, 2020

The FDA approved a cannabidiol oral solution treatment (Epidiolex, Greenwich Biosciences) for seizures associated with tuberous sclerosis complex.

FDA Releases Guidance To Boost Cannabis Clinical Research

July 27, 2020

Responding to growing interest by industry stakeholders, the agency has offered draft guidance outlining quality considerations and other practical recommendations for cannabis and cannabis-derived compounds.

FDA Recommends Naloxone, Opioid Prescribing Rates Drop

July 27, 2020

Health care professionals should consider prescribing naloxone to patients taking prescribed opioids who are at increased risk of opioid overdose, according to the FDA.

Boston Study Finds Discrimination Against Patients with Substance Use Disorder

July 24, 2020

Eighty-one percent of opioid abuse referrals to post-acute care facilities in Massachusetts were rejected, investigators found.

Research Shows Human DNA Affects Gut Bacteria

June 30, 2020

Though the relationship between genetics and gut-dwelling bacteria is still a realm of mystery, new research has begun a new step towards better understanding how one affects the other.

FDA Approves Secukinumab for Treatment of Non-Radiographic Axial Spondyloarthritis

June 17, 2020

FDA approval for the secukinumab (Cosentyx, Novartis) for non-radiographic axial spondyloarthritis was based on results from the PREVENT trial, which showed significant reduction in disease activity.

Clinical Challenge: What Would You Do?

July 13, 2017

Preventing drug-drug interactions with HIV ART

Your New Role in the Battle Against Depression

March 15, 2017

A shortage of mental health-care providers, coupled with pharmacists’ unique skills and access to patients, has led to a significant opportunity for community and health-system pharmacists to aid in detection of depression and in medication selection and counseling for patients with depression.

Alzheimer's Disease: Untapped Potential for Pharmacy

January 18, 2017

Pharmacists can become the perfect partner in the battle against Alzheimer’s disease. Details here.

Are states going too far with painkiller script limits?

December 06, 2016

Arizona has become the latest state to limit opioid prescriptions-a trend that has some healthcare providers and experts concerned.